Munich Re raised its full-year profit target to €6.6 billion after posting a nine-month net result of €5.667 billion, but the more revealing detail in the final quarterly statement is where the earnings came from. Property-casualty reinsurance delivered a combined ratio of 80.0% in Q3, still inside guidance, but the life and health segment grew insurance revenue by 31% year-on-year in the quarter and produced a technical result of €493 million. The result for the period reflects two distinct engines.
The P&C result needs context. Major losses in Q3 came in at €646 million, equating to 14.9% of net insurance revenue against an 18% budget. That is a favorable variance, but not the exceptionally low loss experience that drove Q3 2025’s combined ratio to 62.7%.
Munich Re’s statement attributes the year-on-year decline in the quarterly net result, from €1.997 billion to €1.742 billion, to Q3 2025’s “exceptionally low” major-loss expenditure. The El Choco earthquake in Colombia was the costliest natural catastrophe of the quarter at approximately €0.3 billion. The underlying P&C business performed in line with its own targets.
The segment drawing less attention is doing more structural work. Life and health reinsurance generated a total technical result of €493 million in Q3, up from €314 million a year earlier, as strong new business growth combined with favorable biometric experience, particularly in mortality. Insurance revenue in the segment rose to €3.769 billion from €2.868 billion, with North America, the UK, and Asia all contributing to the expansion. The nine-month technical result reached €1.028 billion against €913 million a year earlier.
A P&C book running in a soft pricing environment is exposed to the mathematics of the renewal cycle, where each successive round of price declines compresses future margin even when current-period results look acceptable. Life and health income, which is less correlated with catastrophe outcomes and renewal pricing cycles, offsets that exposure. Munich Re’s nine-month P&C insurance revenue increased to €13.3 billion, while the L&H segment grew faster in proportional terms.
Munich Re tightened its full-year P&C combined ratio guidance from “approximately 80%” to “less than 80%” alongside the profit target upgrade. That is a directional signal, but it reflects a book that has stayed within its own parameters through three quarters of a softening market.
The context heading into January 2027 is well established. Munich Re deliberately reduced its written volume by 9.1% at the July renewals on a risk-adjusted price decline of 5.5%, and board member Stefan Golling said at Monte Carlo in September that further softening was likely if catastrophe losses remained moderate through year-end. Through nine months they have, with global insured catastrophe losses tracking well below the ten-year average, according to Gallagher Re. That backdrop gives cedants leverage, and Munich Re’s results do not change that arithmetic.
What they do show is that Munich Re is not approaching January from a position of financial stress. The solvency ratio stands at 301%, up from 298% at year-end 2025. The return on equity for the nine-month period was 21.9%.
A reinsurer in that position can afford to maintain discipline on price rather than chase volume, and the July renewals showed that it will. Cedants and brokers negotiating January placements are dealing with a counterparty that has already demonstrated it prefers margin contraction to book growth when the two are in conflict.
Chief financial officer Andrew Buchanan described the result as reflecting “broad diversification of earnings drivers” as a core component of the company’s Ambition 2030 strategy. The nine-month numbers support that characterization.
